The two most lauded drug design approaches from the past century — structure-based design and combinatorial chemistry — are increasingly experiencing integration, whereby the three-dimensional coordinates of a receptor supports the development of combinatorial-based ligand design.
From the heterodimeric complex, chain A (Ubc13) was selected as the receptor (Supporting Methods S1).
As shown in Figure 7B, migrating neuroblasts expressed the CXCR4 receptor, supporting the assumption that SDf-1α gradients participate as guidance cues in neuroblast migration.
Since chemokines remain bound to DARC expressed in the lumen of venules the receptor supports chemokine migratory activity and leukocyte extravasation [41].
The finding that the interaction between pDC and HBV may change upon activation may aid in the identification of a scavenging receptor supporting immunosuppressive effects of HBV and also in the design of novel treatment strategies for chronic HBV.
Our results demonstrate a correlation between loss of cleavage and loss of in vivo function of the Notch receptor, supporting the notion that S1 cleavage is an in vivo mechanism of Notch signal control.
But these authors and others found reduced fibrogenesis following repeated CCl4-administration in animals lacking the TNF-α p55 receptor supporting the involvement of TNF-signaling in CCl4-mediated hepatotoxicity [44], [45].
Downregulation of PTK6 was associated with increased anoikis of BT474 cells and ErbB2 overexpressing MCF-10A cells (NeuN), lines in which anchorage-independent survival is induced via the ErbB2 growth factor receptor, supporting a role for PTK6 in survival of Her2+ cells (Figures 4A and 4B).
